Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab?

Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab? J Rheumatol. 2019 Jun;46(6):550-551 Authors: Mammen AL PMID: 31154443 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31154443?dopt=Abstract

Source: J Rheumatol - May 31, 2019 Category: Rheumatology Authors: Mammen AL Tags: J Rheumatol Source Type: research

More News: Rheumatology | Rituxan